14 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33132262 | [Pharmacological properties and clinical efficacy of dotinurad (URECE® tablets), a novel hypouricemic agent]. | 2020 | 1 |
2 | 29100760 | Comparative study on the interaction between 3 CYP2C9 allelic isoforms and benzbromarone by using LC-MS/MS method. | 2017 Dec 1 | 12 |
3 | 26693855 | Inactivation of CYP3A4 by Benzbromarone in Human Liver Microsomes. | 2016 | 1 |
4 | 23932726 | Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone. | 2014 Mar | 3 |
5 | 24594849 | The curious case of benzbromarone: insight into super-inhibition of cytochrome P450. | 2014 | 3 |
6 | 23229783 | Cytotoxic effects of benzbromarone and its 1'-hydroxy metabolite in human hepatocarcinoma FLC4 cells cultured on micro-space cell culture plates. | 2013 | 1 |
7 | 20962433 | Benzbromarone pharmacokinetics and pharmacodynamics in different cytochrome P450 2C9 genotypes. | 2010 | 5 |
8 | 18636784 | A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? | 2008 | 3 |
9 | 16815961 | Amiodarone analog-dependent effects on CYP2C9-mediated metabolism and kinetic profiles. | 2006 Oct | 2 |
10 | 15843486 | Three-dimensional quantitative structure-activity relationship analysis of cytochromes p450: effect of incorporating higher-affinity ligands and potential new applications. | 2005 Jul | 2 |
11 | 15955872 | CYP2C9 genotype-dependent effects on in vitro drug-drug interactions: switching of benzbromarone effect from inhibition to activation in the CYP2C9.3 variant. | 2005 Sep | 7 |
12 | 15170332 | Quantitative binding models for CYP2C9 based on benzbromarone analogues. | 2004 Jun 8 | 3 |
13 | 12814975 | A new class of CYP2C9 inhibitors: probing 2C9 specificity with high-affinity benzbromarone derivatives. | 2003 Jul | 1 |
14 | 10613612 | Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone. | 1999 Dec | 3 |